Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Chronic cerebrospinal venous insufficiency: pitfalls and perils of sonographic assessment.
Specific Depletion of Myelin-Reactive B Cells via BCR-Targeting.
Investigation of Fatigability during Repetitive Robot-Mediated Arm Training in People with Multiple Sclerosis.
The analysis of semantic networks in multiple sclerosis identifies preferential damage of long-range connectivity.
Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways.
The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis.
Neuromyelitis optica spectrum disorders may be misdiagnosed as Wernicke's encephalopathy.
High-resolution melting analysis for mutation scanning in the non-coding control region of JC polyomavirus from patients with progressive multifocal leukoencephalopathy.
A case of neuromyelitis optica misdiagnosed as cervicogenic headache.
Role of serum TRAIL level and TRAIL apoptosis gene expression in multiple sclerosis and relation to brain atrophy.
Expression, Regulation and Function of MicroRNAs in Multiple Sclerosis.
Natalizumab and fingolimod: Insight into their relative efficacies in clinical practice.
[Alemtuzumab for relapsing-remitting multiple sclerosis : Results of two randomized controlled phase III studies.]
Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool.
Multiple sclerosis in pregnancy.
Meta-Analysis of the Correlation Between Chronic Cerebrospinal Venous Insufficiency and Multiple Sclerosis.
Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis.
A novel nanoparticle containing MOG peptide with BTLA induces T cell tolerance and prevents multiple sclerosis.
Revised diagnostic criteria of multiple sclerosis.
Microarray gene expression profiling analysis combined with bioinformatics in multiple sclerosis.
[Optic neuritis--immunological approach to elucidate pathogenesis and develop innovative therapy].
Hospitalization rates and discharge status in multiple sclerosis.
Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis.
A modality-agnostic patch-based technique for lesion filling in multiple sclerosis.
Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination.

Pages